Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
liver toxicity
Biotech
Rapt faces clinical hold after liver failure in immunology trial
Rapt is reeling from an “unfortunate and unexpected” clinical hold after a patient in a phase 2 immunology trial experienced liver failure.
Max Bayer
Feb 20, 2024 10:42am
Astellas finds underlying liver issues in gene therapy deaths
Nov 16, 2023 7:12am
Merck KGaA grows Quris toxicity AI pact, continuing deal flurry
Sep 28, 2023 10:10am
Third Harmonic shares sink as trial hit by raised liver enzymes
Dec 15, 2022 8:50am
FDA’s liver safety request set to delay decision on Travere drug
Oct 14, 2022 10:05am
FDA committee takes on complex gene therapy safety questions
Sep 3, 2021 9:58am